269
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Multiple Evanescent White Dot Syndrome and Choroidal Neovascularization following SARS-COV-2 Infection in a Patient on Dabrafenib and Trametinib

, MD, FEBO, , MD, FRCOphth, , MD, FRCOphth & , MD, FRCOphth
Pages 641-648 | Received 27 Sep 2021, Accepted 31 Jan 2022, Published online: 28 Feb 2022

References

  • Jampol LM, Sieving PA, Pugh D, Fishman GA, Gilbert H. Multiple evanescent white dot syndrome, I: clinical findings. Arch Ophthalmol. 1984;102:671‐674. doi:10.1001/archopht.1984.01040030527008.
  • Tavallali A, Yannuzzi LA. MEWDS, common cold of the retina. J Ophthalmic Vis Res. 2017;12:132–134. doi:10.4103/jovr.jovr_241_16.
  • Wyhinny GJ, Jackson JL, Jampol LM, Caro NC. Subretinal neovascularization following multiple evanescent white-dot syndrome. Arch Ophthalmol. 1990;108(10):1384–1385. doi:10.1001/archopht.1990.01070120030013.
  • Bryan RG, Freund B, Yannuzzi LA, Spaide RF, Huang S, Costa DL. Multiple evanescent white dot syndrome in patients with multifocal choroiditis. Retina. 2002;22:317–322. doi:10.1097/00006982-200206000-00010.
  • Tsai L, Jampol LM, Pollock SC, et al. Chronic recurrent multiple evanescent white dot syndrome. Retina. 1994;14:160–163. doi:10.1097/00006982-199414020-00009.
  • McCulloch DL, Marmor MF, Brigell MG, et al. ISCEV standard for full-field clinical electrophysiology (2015 update). Doc Ophthalmol. 2015;130(1):1–12. doi:10.1007/s10633-014-9473-7.
  • Machida S, Fujiwara T, Murai K, Kubo M, and Kurosaka D. Idiopathic choroidal neovascularization as an early manifestation of inflammatory chorioretinal diseases. Retina. 2008;102(7):971–976.
  • Mathis T, Delaunay B, Cahuzac A, Vasseur V, Mauget-Faysse M, Kodjikian L. Choroidal neovascularization triggered multiple evanescent white dot syndrome (MEWDS) in predisposed eyes. Br J Ophthalmol. 2018;102:971–976. doi:10.1136/bjophthalmol-2017-311005.
  • Cicinelli MV, Hassan OM, Gill MK, Goldstein D, Battaglia Parodi M, and Jampol LM. A multiple evanescent white dot syndrome-like reaction to concurrent retinal insults. Ophthalmol Ret. 2021;5(10):1017–1026 .
  • Figueroa MS, Ciancas E, Mompean B, Quereda C. Treatment of multiple evanescent white dot syndrome with cyclosporine. Euro J Ophthalmol. 2001;11:86–88. doi:10.1177/112067210101100118.
  • Rouvas AA, Ladas ID, Papakostas TD, Moschos MM, Vergados I. Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to multiple evanescent white dot syndrome. Eur J Ophthalmol. 2007;17(6):996–999. doi:10.1177/112067210701700623.
  • Battaglia Parodi M, Iacono P, Zucchiatti I, Bandello F. Choroidal neovascularization associated with multiple evanescent white dot syndrome treated with intravitreal ranibizumab. Ocul Immunol Inflamm. 2018;26(4):608–611. doi:10.1080/09273948.2016.1247175.
  • Chen KC, Marsiglia M, and Dolz-Marco R, et al. Foveal exudate and choroidal neovascularization in atypical cases of multiple evanescent white dot syndrome. Retina . 2017;37(11):2025–2034.
  • Demirel S, Yalcindag N, Yanik O, Temel E, Batioglu F, Ozmert E. Unusual presentation of multiple evanescent white dot syndrome and importance of optical coherence tomography angiography to diagnose choroidal neovascularization under inflamed choriocapillaris. Indian J Ophthalmol. 2021;68(9):1948–1950. doi:10.4103/ijo.IJO_1115_20.
  • Savastano MC, Rispoli M, Lumbroso B. Choroidal juxtapapillary neovascularization regression in multiple evanescent white dot syndrome by optical coherence tomography angiography: a case report. J Med Case Rep. 2019;13:274. doi:10.1186/s13256-019-2211-8.
  • Burke T, Addison PKF, Pavesio CE. Multifocal evanescent white dot syndrome-like phenotypes associated with inflammatory and myopic choroidal neovascularization. Ocul Immunol Inflamm. 2021;14:1–8. doi:10.1080/09273948.2021.1936563.
  • Papadia E, Herbort CP. Idiopathic choroidal neovascularization as the inaugural sign of multiple evanescent white dot syndrome. Middle East Afr J Ophthalmol. 2010;17(3):270–274. doi:10.4103/0974-9233.65490.
  • Morizot E, Schiavo Froner C. Neovessel as first manifestation of relapse of associated multifocal choroiditis and MEWDS. Int J Retin Vitr. 2019;5:25. doi:10.1186/s40942-019-0175-x.
  • McCollum JC, Kimble JA. Peripapillary subretinal neovascularization associated with multiple evanescent white dot syndrome. Arch Ophthalmol. 1992;110:13–15. doi:10.1001/archopht.1992.01080130015007.
  • Callanan D, Gass JDM. Multifocal choroiditis and choroidal neovascularization associated with the multiple evanescent white dot and acute idiopathic blind spot enlargement syndrome. Ophthalmol. 1992;99:1678–1685. doi:10.1016/S0161-6420(92)31755-5.
  • Oh KT, Christmas NJ, Russell SR. Late recurrence and choroidal neovascularization in multiple evanescent white dot syndrome. Retina. 2001;21(2):182–184. doi:10.1097/00006982-200104000-00017.
  • Low U, Palmowski AM, Weich CM, Ruprecht KW. Choroidal neovascularization followed in a patient with ‘multiple evanescent white dot syndrome’ (MEWDS) – a case report. Klin Monbl Augenheilkd. 2004;221(12):1051–1053. doi:10.1055/s-2004-813823.
  • Fernandez-Barrientos Y, Diaz-Valle D, Mendez-Fernandez R, Benitez-Del-Castillo JM. Possible recurrent multiple evanescent white dot syndrome and choroidal neovascularization. Arch Soc Esp Ophthalmol. 2007;82(9):587–590.
  • Pece A, Allegrini D, Kontadakis S, Querques G, Rossetti L. Intravitreal ranibizumab for choroidal neovascularization in a patient with angioid streaks and multiple evanescent dots. BMC Ophthalmol. 2016;16:122. doi:10.1186/s12886-016-0307-0.
  • Nozaki M, Hamada S, Kimura M, Yoshida M, Ogura Y. Value of OCT-angiography in the diagnosis of choroidal neovascularization complicating multiple evanescent white dot syndrome. Ophthalmic Surg Lasers Imaging Retina. 2016;47:580–584. doi:10.3928/23258160-20160601-11.
  • Jampol LM, Tauscher R, Schwarz HP. COVID-19, COVID-19 vaccinations, and subsequent abnormalities in the retina causation or coincidence? JAMA Ophthalmol. 2021 Sept 2;139:1135. doi:10.1001/jamaophthalmol.2021.3483. Online ahead of print.
  • Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104(6):748–751. doi:10.1136/bjophthalmol-2020-316304.
  • Robbins SG, Detrick B, and Hooks JJ. Retinopathy following intravitreal injection of mice with MHV strain JHM. Adv Exp Med Biol . 1990;276:519–524.
  • Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi:10.1080/09273948.2020.1738501.
  • Sen M, Honavar SG, Sharma N, Sachdev MSCOVID-19. and eye: a review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol. 2021;69(3):488–509. doi:10.4103/ijo.IJO_297_21.
  • De Salvo G, Meduri A, Vaz-Pereire S, Spencer D. An uncommon cold of the retina. Surv Ophthalmol. 2021: S0039-6257(21) 00178-8. doi:10.1016/j.survophthal.2021.08.006.
  • Robert C, Karaszewska B, Schachter J, et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med. 2015;372(1):30–39. doi:10.1056/NEJMoa1412690.
  • Yang AH, and Huang W . Retinal vein occlusion induced by a MEK 2 inhibitor – impact of oxidative stress on the blood-retinal barrier. In: eds., Lushchak VI, and Gospodaryov DV. Oxidative stress and diseases. Vol. 21. 2012:469–494.
  • Albertini G, Corbelli E, Battaglia Parodi M, Bandello F. Choroidal neovascularization in multifocal choroiditis after dabrafenib and trametinib. Eur J Ophthalmol. 2017;27(6):e184–186. doi:10.5301/ejo.5001013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.